UK issues supply chain guide to prevent drug shortages
Biopharm manufacturers should hold a volume of buffer stock to ensure it can maintain supply during fluctuations in demand, says UK guidance.
Archives for February 7, 2011
Teva gets FDA warning for Jerusalem plant
Israeli drugmaker Teva Pharmaceutical Industries has received a US FDA warning letter criticising laboratory operations at its manufacturing facility in Jerusalem.
Pfizer acquires Danish food supplements operation
Pfizer has acquired the consumer healthcare business of Danish firm Ferrosan for an undisclosed fee in what the pharma giant says, “is an excellent strategic fit that strengthens our presence in dietary supplements”.
Contract manufacturing deals
Outsourcing-pharma.com rounds up the latest manufacturing contracts with news from SCM Pharma, Dalton Pharma Services and AMRI
SPL responds to US FDA warning letter
US Heparin maker Scientific Protein Laboratories (SPL) says it has resolved “many of the issues” addressed in the US Food and Drug Administration (FDA) warning letter it received late last month.
Fast patient recruitment cuts clinical trial carbon footprint
Faster patient recruitment and use of lighter packaging minimise the carbon footprint of clinical trials.
Lotus expands new HQ to house employees
Lotus Pharmaceuticals’ new HQ in Beijing, China will be even bigger after the firm announces plans for employee apartments.
Ohio site joins US Oncology Research Phase I network
US Oncology Research has added a site in Dayton, Ohio, US to its network of Phase I cancer research centres.